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Purpose: We analyzed a series of patients who had undergone laparoscopic partial 
nephrectomies (LPNs) and open partial nephrectomies (OPNs) to compare outcomes 
of the two procedures in patients with pathologic T1a renal cell carcinomas (RCCs).
Materials and Methods: From January 1998 to May 2009, 417 LPNs and 345 OPNs 
were performed on patients with small renal tumors in 15 institutions in Korea. Of the 
patients, 273 and 279 patients, respectively, were confirmed to have pT1a RCC. The 
cohorts were compared with respect to demographics, peri-operative data, and onco-
logic and functional outcomes.
Results: The demographic data were similar between the groups. Although the tumor 
location was more exophytic (51% vs. 44%, p=0.047) and smaller (2.1 cm vs. 2.3 cm, 
p=0.026) in the LPN cohort, the OPN cohort demonstrated shorter ischemia times (23.4 
min vs. 33.3 min, p＜0.001). The LPN cohort was associated with less blood loss than 
the OPN cohort (293 ml vs. 418 ml, p＜0.001). Of note, two patients who underwent 
LPNs had open conversions and nephrectomies were performed because of intra-oper-
ative hemorrhage. The decline in the glomerular filtration rate at the last available 
follow-up (LPN, 10.9%; and OPN, 10.6%) was similar in both groups (p=0.8). Kaplan- 
Meier estimates of 5-year local recurrence-free survival (RFS) were 96% after LPN and 
94% after OPN (p=0.8).
Conclusions: The LPN group demonstrated similar rates of recurrence-free survival, 
complications, and postoperative GFR change compared with OPN group. The LPN 
may be an acceptable surgical option in patients with small RCC in Korea.
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INTRODUCTION
Open nephron-sparing surgery (NSS) is effective for the 
management of T1a (≤4 cm) renal cell carcinoma (RCC) 
[1,2]. Initially reserved for patients in whom preservation 
of renal function was needed with durable long-term suc-
cess [3], NSS has been increasingly offered to patients with 
normal contralateral kidneys [4]. The widespread in-
clusion of laparoscopic partial nephrectomy (LPN) in the 
surgical armamentarium for the management of renal can-Korean J Urol 2010;51:467-471
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OPN LPN p-value
No. of patients 279 273
Age (years)   53.1±13.2 54.6±13.2     0.188
a
Sex
  Male (%)  207 (74.2) 191 (70.0)     0.268
b
  Female (%)    72 (25.8)   82 (30.0)
BMI 24.6±3.1 24.7±2.9     0.655
a
Tumor size (cm)   2.3±0.9 2.1±0.8     0.026
a
Tumor side
  Left (%) 130 (49.1)   87 (44.8)     0.113
b
  Right (%) 135 (50.9) 107 (55.2)
Tumor location
  Exophytic (%) 122 (43.7) 140 (51.3)     0.047
b
  Mesophytic (%)   62 (22.2)   69 (25.3)
  Endophytic (%)   86 (30.8)   56 (20.5)
  Hilar (%)   9 (3.2)   8 (2.9)
Operative time  (min) 184±68 221±84 ＜0.001
a
Ischemia time (min) 23.4±9.4 33.3±15.0 ＜0.001
a
Blood loss (ml)   418±370 293±223 ＜0.001
a
Transfusion
 incidence (%)
  47 (16.6) 26 (9.5)     0.011
a
Tumor type
  Clear cell (%) 242 (86.7) 233 (85.3)     0.610
b
  Papillary (%) 23 (8.2) 27 (9.9)
  Chromophobe (%) 13 (4.7) 10 (3.7)
  Unclassified  (%)  1 (0.4)   3 (1.1)
Margin positive (%)  7 (2.5) 12 (4.4)     0.161
a
Recurrence (%)  9 (3.2)   4 (1.5)     0.796
a
Recurrence site
  Tumor bed (%)  3 (1.1)    2 (0.7)
  Adrenal gland (%)  3 (1.1) 0 (0)
  Pancreas (%)  1 (0.4) 0 (0)
  Lymph node (%)  2 (0.8)   1 (0.5)
  Lung (%)        0 (0)   1 (0.5)
Followup (months)    28.0±20.9 17.8±13.0 ＜0.001
a
Death
  RCC (%) 0 (0) 0 (0)
  Other reason (%)  3 (1.1)   4 (2.1)
RCC: renal cell carcinoma, OPN: open partial nephrectomy, LPN: 
laparoscopic partial nephrectomy, BMI: body mass index, 
a:
 the 
Student’s t test was applied for comparison of continuous varia-
bles, 
b:
 the Pearson chi-square test and Fisher exact test were used 
to compare categorical variables
TABLE 1. Demographics and peri-operative data of T1a RCC 
patients
cer, however, has evolved slowly because of technical diffi-
culties related to the procedure [5].
　Originally, LPN was restricted to small, exophytic, and 
peripheral tumors. With increasing experience, however, 
indications for LPN have expanded to more complex tu-
mors, albeit in the hands of laparoscopic experts [6]. 
Current advances in laparoscopic surgery, such as knot-ty-
ing aids [7], hemostatic agents [8,9], intra-operative ma-
neuvers [10], and newer laparoscopic instrumentation 
[11], have greatly helped to make this procedure techni-
cally feasible and reproducible by a wider range of sur-
geons. LPN is thus becoming a valid alternative when NSS 
is considered. In a European study, LPN provided results 
similar to open surgery [12]. We present the Korean experi-
ence comparing LPN with open NSS for the management 
of renal tumors.
MATERIALS AND METHODS
1. Patients 
Between January 1998 and May 2009, 417 consecutive pa-
tients underwent LPN for the management of renal tumors 
by surgeons of 15 institutions in Korea. Of the 417 patients, 
273 met the inclusion criteria of solitary, pathologic T1a tu-
mors (≤4 cm) without a history of ipsilateral renal surgery. 
Thirty-nine patients underwent robot-assisted LPN. These 
patients were compared with a cohort of 279 patients who 
underwent open partial nephrectomy (OPN) performed by 
the same surgeons between January 1998 and May 2009; 
these patients also met the same inclusion criteria. The 
techniques used for both LPN and OPN have been pre-
viously described [7,13].
2. Tumor staging 
Tumour staging was performed according to the 2002 TNM 
system in both groups.
3. Peri-operative analysis and follow-up
Renal function was assessed by measurement of serum 
creatinine. To improve the accuracy of renal function deter-
mination, the glomerular filtration rate (GFR) was esti-
mated using the Mayo Clinic Quadratic Equation (MCQE), 
thereby lowering the effect of underestimation of a high 
GFR compared to other estimation formulae [14]. Renal 
function was graded as suggested by the US National 
Kidney Foundation [15]. Complications were rated as in-
tra- and post-operative and graded according to the 
National Cancer Institute Common Toxicity Criteria 
(NCI-CTC)-based grading system developed by Simmons 
and Gill [16]. Most of the patients were followed at each in-
stitution, with serum creatinine analysis, urinalysis, and 
renal imaging (mainly CT scans) at 6-month intervals for 
3 years and thereafter at yearly intervals. 
4. Statistical analysis
The stage of renal cell cancer was pT1 in all cases. The two 
groups were compared regarding surgical, clinical, and 
pathologic outcome variables. The Student’s t test was ap-
plied for comparison of continuous variables. The Pearson 
chi-square test and Fisher’s exact test were used to com-
pare categorical variables. The five-year overall and re-
currence-free survival (RFS) rates for local and distant re-
lapse in pT1 stage RCC were estimated using the 
Kaplan-Meier method with log-rank test statistics. All 
analyses were performed using the Statistical Package for 
the Social Sciences (version 17; SPSS, Chicago, IL, USA), 
with a two-sided p-value＜0.05 considered to indicate stat-
istical significance.Korean J Urol 2010;51:467-471
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OPN LPN p-value
Intraoperative 4 (1.4%) 3 (1.1%) 0.725
4 Hemorrhage/conversion 2 Hemorrhage/conversion
1 Spleen injury-repair
Minor complications 8 (2.9%) 7 (2.6%) 0.827
4 Delayed bleeding-transfusion 3 Delayed bleeding-transfusion
3 Wound infection 2 Ileus
1 Pleural effusion 2 Wound infection
Major complications 7 (2.5%) 8 (2.9%) 0.761
3 Urinary leakage 3 Pseudoaneurysm-angioembolism
2 Pseudoaneurysm-angioembolism 3 Urinary leakage
1 Low O2 saturation-ICU care 1 Patella fracture due to postop. delirium
1 CO2 retentions-ICU care
Total complications 19 (6.8%) 18 (6.6%) 0.919
Complications by Clavien system, Minor complications: grade 1 complications (minor with bedside treatment required), Major compli-
cations: grades 2-4 (more extensive therapy required, 2A: transfusion and drug therapy, 2B: invasive therapeutic procedures, 3: residual
disability or organ loss, 4: post-operative death), RCC: renal cell carcinoma, OPN: open partial nephrectomy, LPN: laparoscopic partial
nephrectomy, ICU: intensive care unit
TABLE 2. Complications of T1a RCC patients
OPN LPN p-value
Mean preoperative GFR (ml per min/1.72 m
2) 84.9±2.0 (26.8–129.9) 88.9±2.4 (26.6–147.7) 0.2
Mean postoperative GFR (ml per min/1.72 m
2) 76.5±2.3 (22.8–130.1) 80.9±2.6 (24.1–142.5) 0.5
Percent decline in GFR from pre- to postoperative  10.6 10.9 0.8
OPN: open partial nephrectomy, LPN: laparoscopic partial nephrectomy, GFR: glomerular filtration rate
TABLE 3. Renal function outcomes in patients after laparoscopic and open nephron-sparing surgery
RESULTS
The groups were similar with respect to age, gender, and 
body mass index (Table 1). The pre-operative creatinine 
level was similar in both groups. Despite matching for tu-
mors＜4 cm in size, a significant mean difference in tumor 
size existed between the OPN and LPN cohorts; however, 
it was only a 2 mm difference on average between the 
groups.
　LPN was attempted to replicate the surgical technique 
of OPN with one exception. Eighty OPNs used cold ische-
mia, while all LPNs were performed with warm ischemia 
(WI). Other notable findings between the two procedures 
included a longer mean surgical time in the LPN group com-
pared to the OPN group (221 min vs. 184 min, p＜0.001) 
and a longer ischemia time (33.3 min vs. 23.4 min, p＜ 
0.001). The surgical and ischemic times of robot-assisted 
LPN were 245±92 min and 30.1±16.2 min, respectively, 
which were similar to non robot-assisted LPN (p=0.231 and 
p=0.078, respectively). LPNs were associated with less es-
timated blood loss (EBL; 293 ml vs. 418 ml, p＜0.001). The 
mean length of follow-up of the OPN group was longer than 
the LPN group (28.0 months vs. 17.8 months, p＜0.001). 
　The final pathology report revealed clear-cell carcinoma 
in 86.7% and 85.3% of the OPN and LPN patients, re-
spectively (p=0.611). Twelve (4.4%) and 7 positive margins 
(2.5%) occurred in the LPN and OPN cohorts, respectively 
(p=0.161). 
　Open conversion was required in 2 patients (0.7%) in the 
LPN group because of intra-operative hemorrhage and 
radical nephrectomies were performed. Radical con-
version occurred in 4 of the OPN patients (1.4%) due to in-
tra-operative hemorrhage. 
　The overall incidence of intra-operative complications 
was similar in both arms (Table 2). The following three in-
tra-operative complications occurred in the LPN patients: 
a spleen injury that was repaired laparoscopically and two 
open conversions secondary to hemorrhage. The total com-
plications were similar in both cohorts (OPN, 6.8%; LPN, 
6.6%; p=0.919). When complications were stratified, minor 
and major complications were similar between the two 
groups. The majority of these complications were pseudoa-
neurysms, which were repaired by angioembolization in 
five patients in both arms. Post-operative urine leakage de-
veloped in three patients who underwent OPNs; two of the 
patients were managed with prolonged Jackson-Pratt 
drainage, and the third patient needed percutaneous 
drains. Three patients with urinary leakage in the LPN co-
hort were treated conservatively with prolonged Jackson- 
Pratt drainage.
　The short-term oncologic outcome and early recurrence 
were similar in both arms. Local recurrences were found 
in both groups (LPN, 0.7% [n=2]; OPN, 1.0% [n=3]); 0.7% 
(n=2) and 2.1% (n=6) of the patients developed distant Korean J Urol 2010;51:467-471
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FIG. 1. Recurrence-free probability curves demonstrating no 
difference in outcomes for T1a RCC patients undergoing open 
and laparoscopic partial nephrectomies (log-rank p=0.332). 
RFS: recurrence-free survival, OPN: open partial nephrectomy,
LPN: laparoscopic partial nephrectomy, NSS: nephron-sparing
surgery, RCC: renal cell carcinoma.
metastases to the liver, cecum, lymph nodes, or pancreas 
after LPNs and OPNs, respectively. At 5 years, the Kaplan- 
Meier estimates for recurrence-free rates were 96% and 
94% after LPNs and OPNs, respectively (p=0.332). Three 
and four patients died during follow-up after OPNs and 
LPNs, respectively, but other patients in both groups died 
due to other causes than RCC (Fig. 1).
　The decline in post-operative GFR did not differ between 
the two groups (p=0.8) (Table 3). On multivariate re-
gression analysis, pre-operative GFR and ischemia time 
independently predicted the post-operative GFR decline. 
DISCUSSION
The principal findings of our Korean multicenter study 
were comparable surgical, oncologic, and functional out-
comes after laparoscopic and open NSS. Shorter operative 
and hospitalization times following the laparoscopic ap-
proach reveal advantages in terms of reduced peri-oper-
ative morbidity, as well as non-urologic complications [17]. 
Previously, open NSS was reserved for patients with a soli-
tary kidney or renal insufficiency. With complication rates 
and cancer control rates comparable to those for radical 
nephrectomies for tumors＜4 cm in size, however, partial 
nephrectomy is now viewed as an acceptable alternative for 
many patients with renal masses [18]. Contrary to laparo-
scopic radical nephrectomy, LPN has been slow to become 
an alternative to open NSS; this is caused in large part by 
the very high level of technical expertise needed to perform 
the procedure [6].
　Similar to the large multi-institutional series presented 
by Gill et al [19], blood loss was minimal while ischemia 
time was longer for LPNs. In our series, however, we did 
not find a greater rate of intra- or post-operative complica-
tions, as reported by Gill et al [19]. Their series had sig-
nificantly more post-operative complications in the LPN 
group (24.9%, LPN; 19.2%, OPN), although the series pre-
sented by Schiff and coworkers [17] (9%, LPN; 19%, OPN) 
and our group (6.6%, LPN; 6.8%, OPN; p=0.919) found the 
opposite. This may be attributed to the small difference in 
mean tumor size and tumor location between Gill’s series 
[19] and our series. Tumors in the OPN cohort, however, 
were on average only 5 mm larger than tumors in the LPN 
cohort in our series, which is less than that presented by 
Gill et al [19] (3.5 cm, OPN; 2.7 cm, LPN) and Schiff [17] 
(3.4 cm, OPN; 2.2 cm, LPN). Overall complication rates for 
LPN in the literature range from 6% to 33% and for OPN 
from 4.1% to 38.6% [12,20-22]. Our retrospective multi-
center study did not regard blood transfusion due to hemor-
rhage as a post-operative complication because the in-
dications for blood transfusion at each institution and for 
each physician were different. However, simply adding the 
transfusion rate to the complication rate for LPNs and 
OPNs yielded 16.1% and 23.6%, respectively; these results 
were similar to a previous Western study [20-22].
　Also in our analysis, data on the oncologic outcome must 
be interpreted with caution because of the rather short follow- 
up. The Cleveland Clinic Foundation reported excellent re-
sults, with 100% distant and 97.3% local recurrence-free 
survivals within 5.7 years of LPNs [23]. Canes presented 
comparable 97.5% and 98.3% distant and local recurrence- 
free survival estimates, respectively, at 5 years for OPNs 
[24]. Similar data have been reported by others [21]. Our 
data suggest that open and laparoscopic access yield com-
parable oncologic efficacy in the treatment of pT1 stage 
RCC. The impact of positive margins on disease outcome 
has been discussed controversially. As we observed similar 
rates of positive surgical margins in LPNs and OPNs, it may 
be that the limited maneuverability of laparoscopic instru-
ments does not significantly affect the accuracy of tumor 
excision. A multicenter analysis of LPNs showed positive 
margins in 1.8-2.4% of cases [24], and a slightly higher rate 
of 6.7% in solitary kidneys [25]. The positive surgical mar-
gin rate of OPNs is similar, with 7% in an analysis of 777 
patients by Kwon et al [26]. The positive surgical margin 
rate of LPNs and OPNs was 4.4% and 2.5 %, respectively, 
in the current study. It is important to understand that pos-
itive margin status does not necessarily indicate residual 
disease or translate into disease progression, as only 4% of 
patients with positive margins will eventually develop lo-
cal recurrences [26]. Nevertheless, patients with positive 
surgical margins require close post-operative monitoring.
　Marszalek et al reported that the decline in the GFR at 
the last available follow-up (LPN, 10.9%; OPN, 10.6%) was 
similar in both OPN and LPN groups (p=0.8) [12]. In the 
current study, the decline in renal function was similar af-
ter LPNs and OPNs despite a longer WIT in LPN patients. 
Based on a multivariate analysis, laparoscopic access was 
not an independent risk factor for GFR impairment in the 
post-operative phase. Pre-operative renal function was, 
besides ischemic time, one predictive factor for the long- 
term decline in GFR in our study. Our study did not show Korean J Urol 2010;51:467-471
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the beneficial effect of the robot system on ischemic time 
because robot-assisted LPN was in its infancy of use in 
Korean institutions for partial nephrectomies.
　We acknowledge that the retrospective nature of the 
analysis is a shortcoming of this study. It was likely that 
complication rates were under-reported. Furthermore, 
non-identical protocols from multi-institutions might have 
reduced the statistical power in analysis so that some asso-
ciations were not detected. Long-term follow-up is needed 
to verify long-term oncologic and functional outcomes.
CONCLUSIONS
The LPN group demonstrated similar rates of recurrence- 
free survival, complications, and postoperative GFR change 
compared with OPN group. The LPN may be an acceptable 
surgical option in patients with small RCC in Korea.
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